The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Employment - Lilly (I)
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; MSD; Novartis; Ono Pharmaceutical; Pfizer; Quintiles; Roche; Sumitomo Group; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Chugai Pharma; Lilly; Merck Serono; MSD; Nitto Denko; Pfizer
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Chugai Pharma (Inst); Kiowa Kirin (Inst); Kyorin; Lilly (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Regeneron; Taiho Pharmaceutical (Inst)
KEYNOTE-604: Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy for extensive-stage (ES) small-cell lung cancer (SCLC).
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Amgen; Ascentage Pharma; AstraZeneca; Bicycle Therapeutics; Bridge Medicines; Celgene; Daiichi Sankyo; Genentech/Roche; Harpoon Therapeutics; Ipsen; Loxo; PharmaMar; PharmaMar
Research Funding - Abbvie/Stemcentrx (Inst); Daiichi Sankyo (Inst); Merck (Inst); Viralytics (Inst)
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; Achilles Therapeutics; ARIAD; AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Foundation Medicine; Genentech; Gritstone Bio; Hengrui Therapeutics; Maverick Therapeutics; Merck; Nektar; Neon Therapeutics; Novartis; Pfizer; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Alejandro Navarro
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche
Expert Testimony - Oryzon Genomics
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer
 
Maya Gottfried
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Solange Peters
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Illumina (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Biocartis (Inst); Bioinvent (Inst); Blueprint Medicines; Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo; Debiopharm Group (Inst); Illumina (Inst); Incyte; Janssen (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Takeda (Inst); Vaccibody (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Biodesix (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Illumina (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Incyte; MSD; Roche; Sanofi
(OPTIONAL) Uncompensated Relationships - ESMO; European Thoracic Oncology Platform (ETOP); Journal of Thoracic Oncology
 
Tibor Csőszi
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Roche
 
Parneet Kaur Cheema
Honoraria - AstraZeneca; Merck; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Emd serono; Genomic Health; Merck; Novartis; Pfizer; Roche; Takeda
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Mira Wollner
Honoraria - AstraZeneca; Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche Israel (Inst); takeda
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche Israel
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer
 
Grzegorz Czyzewicz
Research Funding - MSD (Inst)
 
James Chih-Hsin Yang
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Ono Pharmaceutical; Pfizer; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Amgen; Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Blueprint Medicines; Boehringer Ingelheim; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; G1 Therapeutics; Hansoh; Incyte; Lilly; Merck Serono; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech; Takeda; Yuhan
Travel, Accommodations, Expenses - Pfizer
 
Julien Mazieres
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly/ImClone; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Francisco J Orlandi
Honoraria - Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - AstraZeneca/MedImmune; Roche
Research Funding - Amgen; Astellas Medivation; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Celltrion; Genentech/Roche; mAbxience; MSD Oncology; Nektar; Pfizer; Sanofi
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Genentech/Roche; MSD Oncology; Pfizer; Roche
 
Alexander Luft
No Relationships to Disclose
 
Mahmut Gumus
Consulting or Advisory Role - Amgen (Inst); Lilly (Inst); Roche
Speakers' Bureau - MSD Oncology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Terufumi Kato
No Relationships to Disclose
 
Gregory Peter Kalemkerian
Consulting or Advisory Role - BioMed Valley Discoveries (I); Boston Biomedical (I); Molecular Templates (I); Skyline Biosciences (I); Synlogic (I); Takeda (I); Unum Therapeutics (I)
Research Funding - Abbvie (Inst); Merck (Inst); Takeda (Inst)
 
Yiwen Luo
No Relationships to Disclose
 
Maria Catherine Pietanza
Employment - Merck
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Hye Ryun Kim
Stock and Other Ownership Interests - Bridgebio
Consulting or Advisory Role - MSD
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Ono Pharmaceutical; Roche